Literature DB >> 6420328

Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations.

G Mauff, K Bender, C M Giles, S Goldmann, W Opferkuch, B Wachauf.   

Abstract

Ten families with 82 members were investigated for C4A- and B polymorphism in a blind trial. Phenotyping was done on neuraminidase treated sera by immunofixation and simultaneously by hemolytic overlay electrophoresis. In addition Rg, Ch, BF, C2, HLA-A, B, C, DR, and GLO were determined. After decoding the samples the reliability of blind typing was found to be 84.4% according to segregation patterns. Inconsistencies occurred mostly when A4, A2, or A92 were present. The detection of silent A*Q0 and B*Q0 alleles was more critical than that of "difficult" allotypes. The quantitation of the C4A/B ratio by densitometry of stained gels or by conventional immunochemical measurements of serum C4 level could not substantially improve the identification of A*Q0 or B*Q0. C4 dependent activity in radial diffusion hemolysis showed satisfactory correspondence with the number of expressed C4B alleles. At least three haplotypes with two C4A genes (duplicated A genes) were observed as ascertained from offspring analysis in accordance with the MHC segregation pattern. Individuals with the duplicated C4A gene (C4A*3, A*2, in the absence of any other expressed A allele or together with C4A*92) showed only partial inhibition of Rodgers antisera. Partial inhibition of Chido antisera was seen in individuals with C4B 2 (in the absence of other B allotypes). The findings support the hypothesis of at least two structural C4 loci. They also demonstrate the inconsistency of quantitative data in the recognition of silent alleles.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420328     DOI: 10.1007/bf00291561

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  ESTIMATION OF MOLECULAR SIZE OF COMPLEMENT COMPONENTS BY SEPHADEX CHROMATOGRAPHY.

Authors:  T BORSOS; H J RAPP
Journal:  J Immunol       Date:  1965-04       Impact factor: 5.422

2.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

3.  Scleroderma: possible significance of silent alleles at the C4B locus.

Authors:  E Mollenhauer; R Schmidt; M Heinrichs; C Rittner
Journal:  Arthritis Rheum       Date:  1984-06

4.  Different HLA antigen associations for the functionally active and inactive products of the complement C4F1 allele.

Authors:  G J O'Neill; P Miniter; M S Pollack; B Dupont
Journal:  Hum Immunol       Date:  1980-07       Impact factor: 2.850

5.  Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand.

Authors:  J Greiner; F J Weber; G Mauff; M Baur
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

6.  Inherited polymorphism of human C4 as revealed by desialyzation.

Authors:  Z L Awdeh; C A Alper
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

7.  Further investigations on the genetics of the C+ protein polymorphism.

Authors:  P Teisberg; B Olaisen; T Gedde-Dahl; E Thorsby; R Nordhagen
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

8.  Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4.

Authors:  W Opferkuch; H J Rapp; H R Colten; T Borsos
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

9.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

10.  Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man.

Authors:  Z L Awdeh; D Raum; E J Yunis; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  10 in total

1.  Analysis of HLA-B35 variants and B35 haplotypes by isoelectric focusing and Southern blot analysis.

Authors:  E Lederer; E Nössner; R Wank; D J Schendel
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Factor B subtyping in sera and bloodstains by isoelectric focusing and immunoblotting.

Authors:  A Kido; N Komatsu; Y Kimura; M Oya
Journal:  Z Rechtsmed       Date:  1990

3.  Human BF*F-subtypes: segregation analysis with inclusion of MHC haplotypes.

Authors:  G Geserick; G Mauff; I Siemens; H Waltz; A Mayer; K Bender; M Rose; S Goldmann; M Brenden; H Schröder
Journal:  Hum Genet       Date:  1989-10       Impact factor: 4.132

4.  Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes.

Authors:  C Rittner; C M Giles; M H Roos; P Démant; E Mollenhauer
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Population and formal genetics of the human C81(alpha-gamma) polymorphism.

Authors:  C Rittner; W Hargesheimer; E Mollenhauer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus.

Authors:  M L Olsen; R Goldstein; F C Arnett; M Duvic; M Pollack; J D Reveille
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  Influence of C4 null alleles on C4 activation in systemic lupus erythematosus.

Authors:  D C Briggs; G Senaldi; D A Isenberg; K I Welsh; D Vergani
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

8.  Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients.

Authors:  P J Hall; S J Burman; M R Laurent; D C Briggs; H E Venning; A M Leak; P A Bedford; B M Ansell
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

9.  HLA haplotypes with C4B5; evidence for further allelic heterogeneity.

Authors:  S N Hing; C M Giles; A H Fielder; J R Batchelor
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

10.  Partial C4 deficiency in subacute sclerosing panencephalitis.

Authors:  C Rittner; E M Meier; B Stradmann; C M Giles; R Köchling; E Mollenhauer; H W Kreth
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.